A forum for researchers, students and applicants in the field of cyclodextrin technology
In this work it is reported a one-pot preparation of dual-redox sensitive, stabilized supramolecular nanocontainers for potential programmable drug release
The incorporation of cyclodextrin moieties into larger structures produces five types of new materials: crosslinked networks, functionalized chains, amphiphilic cyclodextrins,
As the International Cyclodextrin Symposium (Giardini Naxos, Sicily) has been postponed to 2022 an abridged virtual meeting was organized by
A Special issue “Drug-Cyclodextrin Interactions. A Basis for New Formulations” in Molecules (ISSN 1420-3049, http://www.mdpi.com/journal/molecules) will be published. Contributions of either an original research
New leading international life science investors join current institutional investors with proceeds to: Advance novel, late-stage Investigational ophthalmology drugs OCS-01
In this work, the effects of simvastatin (SIM), 2-hydroxypropyl)-β-cyclodextrin (HPβCD) and their complex (SIM: HPβCD) on the structure and properties
The webinar held on Apr. 15-16, 2021 and organized by Cyclolab received wide attantion. It was in the afternoon Central
The Lancet published on an open-label, parallel-group, phase 2, randomised controlled trial, on inhaled budesonide (Ramakrishnan et al. 2021). Participants
Lipid rafts are functional membrane microdomains containing sphingolipids, including gangliosides, and cholesterol. These regions are characterized by highly ordered and
During the webinar of CycloLab “Getting the best out of cyclodextrins” held on Apr.15-16, 2021, the participants could answer to
